What is the latest INDOAMIN stock price?
The latest stored price for INDOAMIN is Rs 126.73 as of 2026-07-21.
gimli
INDOAMIN stock AI analysis
INDOAMIN Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
INDO AMINES LIMITED is a small-cap stock in Chemicals. This Gimli page shows the latest available INDOAMIN price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹126.73
1W return
+1.59%
1M return
-11.72%
3M return
+10.82%
6M return
+12.24%
1Y return
-21.74%
Market cap
₹919.90 cr
PE
11.60
PB
2.34
ROE
+22.30%
ROCE
+19.87%
RSI
47.78
Turnover
₹0.75 cr
Why it can matter in screens
- Momentum: INDOAMIN is below 50DMA, above 200DMA; RSI is 47.78.
- Returns: 1D +5.00%, 1W +1.59%, 1M -11.72%, 3M +10.82%, 1Y -21.74%.
- Trend levels: 52W high ₹161.94, 52W low ₹82.12, off high -21.74%.
- Liquidity: latest turnover is ₹0.75 cr; volume vs 20D is +0.78%.
- Valuation/profitability: PE 11.60, PB 2.34, ROE +22.30%, ROCE +19.87%.
- Growth: 3Y sales CAGR +7.20%, 3Y profit CAGR +24.73%.
Quick Answers
Is INDOAMIN above its 50DMA and 200DMA?
INDOAMIN is below 50DMA, above 200DMA. The latest 50DMA is 129.82 and the latest 200DMA is 121.49.
What are INDOAMIN PE, ROE and ROCE?
INDOAMIN has PE 11.60, ROE +22.30%, and ROCE +19.87% in Gimli's latest available snapshot.
How has INDOAMIN performed recently?
INDOAMIN has returned -11.72% over 1 month, +10.82% over 3 months, and -21.74% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 317.61 cr | 40.12 cr | 20.51 cr | 2.73 |
| 2025-12-31 | 277.42 cr | 27.51 cr | 11.87 cr | 1.62 |
| 2025-09-30 | 277.05 cr | 36.87 cr | 18.11 cr | 2.50 |
| 2025-06-30 | 287.59 cr | 46.83 cr | 28.84 cr | 3.94 |
| 2025-03-31 | 285.41 cr | 25.09 cr | 11.85 cr | 1.68 |
| 2024-12-31 | 258.84 cr | 26.81 cr | 11.31 cr | 1.52 |
| 2024-09-30 | 269.23 cr | 29.32 cr | n/a | 1.91 |
| 2024-06-30 | 264.93 cr | 35.19 cr | 19.31 cr | 2.63 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 1,159.66 cr | 151.34 cr | 79.33 cr | 10.79 |
| 2025-03-31 | 1,078.68 cr | 116.29 cr | 55.90 cr | 7.70 |
| 2024-03-31 | 943.46 cr | 93.88 cr | 42.75 cr | 5.92 |
| 2023-03-31 | 941.24 cr | 89.01 cr | 40.88 cr | 5.78 |
| 2022-03-31 | 779.10 cr | 60.45 cr | n/a | nan |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 897.46 cr | 6.52 cr | 310.88 cr | 393.78 cr |
| 2025-03-31 | 778.75 cr | 2.72 cr | 284.42 cr | 317.64 cr |
| 2024-03-31 | 634.76 cr | 3.83 cr | 216.99 cr | 264.92 cr |
| 2023-03-31 | 597.30 cr | 5.97 cr | 232.07 cr | 225.81 cr |
| 2022-03-31 | 554.46 cr | 6.17 cr | 207.26 cr | 187.70 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 78.80 cr | 0.36 cr | n/a |
| 2025-03-31 | 35.40 cr | -47.78 cr | n/a |
| 2024-03-31 | 69.89 cr | 39.12 cr | n/a |
| 2023-03-31 | 20.36 cr | -10.98 cr | n/a |
| 2022-03-31 | 15.46 cr | -24.27 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +58.42% | +0.02% | +0.00% | +0.00% | +41.56% | +0.00% |
| 2025-12-31 | +58.42% | +0.00% | +0.00% | +0.00% | +41.58% | +0.00% |
| 2025-09-30 | +58.42% | +0.00% | +0.00% | +0.00% | +41.58% | +0.00% |
| 2025-06-30 | +58.42% | +0.03% | +0.00% | +0.00% | +41.55% | +0.00% |
| 2025-03-31 | +58.37% | +0.11% | +0.00% | +0.00% | +41.52% | +0.00% |
| 2025-03-19 | +58.37% | +0.15% | +0.00% | +0.00% | +41.48% | +0.00% |
| 2024-12-31 | +57.25% | +0.16% | +0.00% | +0.00% | +42.59% | +0.00% |
| 2024-09-30 | +57.25% | +0.01% | +0.00% | +0.00% | +42.74% | +0.00% |
| 2024-06-30 | +66.76% | +0.00% | +0.00% | +0.00% | +33.24% | +0.00% |
| 2024-03-31 | +66.76% | +0.05% | +0.00% | +0.00% | +33.19% | +0.00% |
| 2023-12-31 | +66.76% | +0.10% | +0.00% | +0.00% | +33.15% | +0.00% |
| 2023-09-30 | +66.87% | +0.00% | +0.00% | +0.00% | +33.13% | +0.00% |
| 2023-06-30 | +67.37% | +0.00% | +0.00% | +0.00% | +32.63% | +0.00% |
| 2023-03-31 | +67.40% | +0.06% | +0.00% | +0.00% | +32.55% | +0.00% |
| 2022-12-31 | +68.35% | +0.17% | +0.00% | +0.00% | +31.48% | +0.00% |
| 2022-09-30 | +69.03% | +0.06% | +0.00% | +0.00% | +30.91% | +0.00% |
| 2022-06-30 | +69.33% | +0.00% | +0.01% | n/a | n/a | +0.00% |
| 2022-04-22 | +69.33% | +0.00% | +0.00% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SOLARINDS | SOLAR INDUSTRIES (I) LTD | 172,338.40 cr | 102.732196 | +30.27% | +27.60% |
| PIDILITIND | PIDILITE INDUSTRIES LTD | 161,958.58 cr | 65.989994 | +23.37% | +7.34% |
| SRF | SRF LTD | 87,113.72 cr | 47.468762 | +13.76% | -6.11% |
| COROMANDEL | COROMANDEL INTERNTL. LTD | 60,543.98 cr | 31.139858 | +15.97% | -12.18% |
| LINDEINDIA | LINDE INDIA LIMITED | 59,733.05 cr | 108.811304 | +13.58% | +4.71% |
| FACT | FACT LTD | 53,926.98 cr | -1361.792436 | -2.91% | -13.20% |
| UPL | UPL LIMITED | 52,182.33 cr | 26.341406 | +5.01% | -13.39% |
| FLUOROCHEM | GUJARAT FLUOROCHEM LTD | 50,608.99 cr | 87.558812 | +7.60% | +28.93% |
Try these prompts
- Analyze INDO AMINES with valuation, momentum and industry peers
- Compare INDOAMIN with other Chemicals stocks
- Show small-cap stocks in Chemicals above 50DMA with positive 1M return
- Find Chemicals stocks with improving momentum and reasonable valuation
Related screen ideas
- View Chemicals stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare INDOAMIN with other Chemicals stocks
Data snapshot: 2026-07-21. Not investment advice.